8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Astrocyte responses to neuronal injury may be beneficial or detrimental to neuronal recovery, but the mechanisms that determine these different responses are poorly understood. Here we show that ephrin type-B receptor 1 (EphB1) is upregulated in injured motor neurons, which in turn can activate astrocytes through ephrin-B1-mediated stimulation of signal transducer and activator of transcription-3 (STAT3). Transcriptional analysis shows that EphB1 induces a protective and anti-inflammatory signature in astrocytes, partially linked to the STAT3 network. This is distinct from the response evoked by interleukin (IL)-6 that is known to induce both pro inflammatory and anti-inflammatory processes. Finally, we demonstrate that the EphB1–ephrin-B1 pathway is disrupted in human stem cell derived astrocyte and mouse models of amyotrophic lateral sclerosis (ALS). Our work identifies an early neuronal help-me signal that activates a neuroprotective astrocytic response, which fails in ALS, and therefore represents an attractive therapeutic target.

          Abstract

          Astrocytes can have protective or detrimental effects on neurons during injury, but the molecular mechanisms that determine these different states are unresolved. Here the authors identify a pathway via neuronal EphB1 that induces neuroprotective signalling in astrocytes through ephrin-B1 mediated STAT3 activation, which is impaired in models of amyotrophic lateral sclerosis.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular dissection of reactive astrogliosis and glial scar formation.

          Reactive astrogliosis, whereby astrocytes undergo varying molecular and morphological changes, is a ubiquitous but poorly understood hallmark of all central nervous system pathologies. Genetic tools are now enabling the molecular dissection of the functions and mechanisms of reactive astrogliosis in vivo. Recent studies provide compelling evidence that reactive astrogliosis can exert both beneficial and detrimental effects in a context-dependent manner determined by specific molecular signaling cascades. Reactive astrocytes can have both loss of normal functions and gain of abnormal effects that could feature prominently in a variety of disease processes. This article reviews developments in the signaling mechanisms that regulate specific aspects of reactive astrogliosis and highlights the potential to identify novel therapeutic molecular targets for diverse neurological disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reactive gliosis and the multicellular response to CNS damage and disease.

            The CNS is prone to heterogeneous insults of diverse etiologies that elicit multifaceted responses. Acute and focal injuries trigger wound repair with tissue replacement. Diffuse and chronic diseases provoke gradually escalating tissue changes. The responses to CNS insults involve complex interactions among cells of numerous lineages and functions, including CNS intrinsic neural cells, CNS intrinsic nonneural cells, and CNS extrinsic cells that enter from the circulation. The contributions of diverse nonneuronal cell types to outcome after acute injury, or to the progression of chronic disease, are of increasing interest as the push toward understanding and ameliorating CNS afflictions accelerates. In some cases, considerable information is available, in others, comparatively little, as examined and reviewed here. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A census of human transcription factors: function, expression and evolution.

              Transcription factors are key cellular components that control gene expression: their activities determine how cells function and respond to the environment. Currently, there is great interest in research into human transcriptional regulation. However, surprisingly little is known about these regulators themselves. For example, how many transcription factors does the human genome contain? How are they expressed in different tissues? Are they evolutionarily conserved? Here, we present an analysis of 1,391 manually curated sequence-specific DNA-binding transcription factors, their functions, genomic organization and evolutionary conservation. Much remains to be explored, but this study provides a solid foundation for future investigations to elucidate regulatory mechanisms underlying diverse mammalian biological processes.
                Bookmark

                Author and article information

                Contributors
                rickie.patani@ucl.ac.uk
                AL291@cam.ac.uk
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                27 October 2017
                27 October 2017
                2017
                : 8
                : 1164
                Affiliations
                [1 ]ISNI 0000000121885934, GRID grid.5335.0, John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, , University of Cambridge, E.D. Adrian Building, ; Forvie Site, Robinson Way, Cambridge, CB2 0PY UK
                [2 ]ISNI 0000000121901201, GRID grid.83440.3b, Department of Molecular Neuroscience, UCL Institute of Neurology, , University College London, ; London, WC1N 3BG UK
                [3 ]Division of Brain Sciences, Imperial College London, Burlington Danes Building Du Cane Road, London, W12 0NN UK
                [4 ]Institute of Experimental Medicine ASCR and Charles University in Prague, Department of Neuroscience, Videnská 1083, Prague 4, 142 20 Czech Republic
                [5 ]ISNI 0000000121901201, GRID grid.83440.3b, Sobell Department of Motor Neuroscience & Movement Disorders, , UCL Institute of Neurology, University College London, ; London, WC1N 3BG UK
                [6 ]ISNI 0000000121901201, GRID grid.83440.3b, UK Dementia Research Institute at UCL, UCL Institute of Neurology, , University College London, ; London, WC1N 3BG UK
                [7 ]ISNI 0000 0001 0701 8607, GRID grid.28803.31, Waisman Center, , University of Wisconsin, ; 1500 Highland Avenue, Madison, WI 53705 USA
                [8 ]ISNI 0000000121901201, GRID grid.83440.3b, Department of Neuroinflammation, UCL Institute of Neurology, , University College London, ; London, WC1N 1PJ UK
                [9 ]ISNI 0000 0004 1795 1830, GRID grid.451388.3, The Francis Crick Institute, ; 1 Midland Road, London, NW1 1AT UK
                [10 ]ISNI 0000 0004 0383 8386, GRID grid.24029.3d, Addenbrooke’s Hospital, , Cambridge University Hospitals, ; Hills Road, Cambridge, CB2 0QQ UK
                Author information
                http://orcid.org/0000-0002-4319-8745
                Article
                1283
                10.1038/s41467-017-01283-z
                5660125
                29079839
                920c95fe-26e2-4c9a-8b94-3fc1fc494945
                © The Author(s) 2017

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 26 June 2016
                : 6 September 2017
                Categories
                Article
                Custom metadata
                © The Author(s) 2017

                Uncategorized
                Uncategorized

                Comments

                Comment on this article